Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Stock Research Report for MRK as of 9/8/11 - Chaikin Power Tools


Published on

To order a free Chaikin Power Gauge stock research report for MRK go to

Published in: Business, Economy & Finance
  • Be the first to comment

  • Be the first to like this

Stock Research Report for MRK as of 9/8/11 - Chaikin Power Tools

  1. 1. Merck & Co Inc (MRK) Price: $32.93 Industry: Drugs Chaikin Power Gauge Report | Generated: Thu Sep 08 17:09 EDT 2011 MRK Merck & Co Inc $32.93 Power Gauge Rating MRK - Neutral TM The Chaikin Power Gauge Rating for MRK is neutral with average financial metrics, weak earnings performance, bullish price/volume activity and very positive expert opinions. Financial Metrics Expert opinions about MRK are very positive which is evidenced by a very low Earnings Performance short interest ratio. Price/Volume Activity MRKs earnings performance is weak as a result of a relatively poor trend in earnings this year. Expert Opinions Despite these bullish factors, Chaikin Power Tools has identified a negative trend resulting in a neutral rating. News Sentiment Rating Neutral MRK Merck & Co Inc August 24, 2011 TM Chaikin Sentiment Gauge for MRK is neutral. Stories concerning MRK have a balanced or neutral sentiment. News Sentiment :Neutral Power Trend - 5 Year Chart The Power Gauge distills a 20 factor model into a concise picture of a stocks potential. High Potential Neutral Low PotentialI want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
  2. 2. Financials & Earnings Financial Metrics Financial Metrics Rating LT Debt/Equity Ratio Neutral Price to Book Value MRKs financial metrics are neutral. The company has high revenue per share and is carrying too much long term debt. Return on Equity The rank is based on a high long term debt to equity ratio, low price to sales ratio and relatively low cash flow. Price to Sales Ratio Business Value Assets and Liabilities Valuation Returns Ratio TTM Ratio TTM Ratio TTM Current Ratio 2.05 Price/Book 1.76 Return on Invest 15.4% LT Debt/Equity 0.27 Price/Sales 2.21 Return on Equity 19.5% Earnings Performance Earnings Performance Rating Earnings Growth Bearish Earnings Surprise MRKs earnings performance has been weak. The company experienced relatively poor earnings growth in the past 12 months and is priced relatively high compared to next years projected EPS. Earnings Trend The rank is based on high earnings growth over the past 3-5 years, a relatively Projected P/E Ratio poor trend in earnings this year, a relatively high projected P/E ratio and consistent earnings over the past 5 years. Earnings Consistency 5 Year Revenue and Earnings Growth EPS Estimates 12/06 12/07 12/08 12/09 12/10 Factor Actual EPS Prev EST EPS Current Change Revenue(M) 22,636.00 24,197.70 23,850.30 27,428.30 45,987.00 Quarterly EPS $0.11 $0.90 +0.79 Rev % Growth 2.84% 6.90% -1.44% 15.00% 67.66% Yearly EPS $0.28 $3.73 +3.45 EPS $2.03 $1.49 $3.64 $5.65 $0.28 Factor Actual EPS Growth Est EPS Growth Change EPS % Growth -3.33% -26.60% 144.30% 55.22% -95.04% 3-5 year EPS 18.19% 3.25% -14.94 EPS Surprise EPS Quarterly Results Estimate Actual Difference % Difference FY Qtr 1 Qtr 2 Qtr 3 Qtr 4 Total Latest Qtr $0.95 $0.95 $0.00 0.00 12/09 $0.68 $0.74 $1.61 $2.35 $5.38 1 Qtr Ago $0.84 $0.92 $0.08 9.52 12/10 $0.09 $0.24 $0.11 $-0.17 $0.27 2 Qtr Ago $0.83 $0.88 $0.05 6.02 12/11 $0.34 $0.65 - - - 3 Qtr Ago $0.83 $0.85 $0.02 2.41 Fiscal Year End Month is December. I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
  3. 3. Price Trend & Expert Opinions Price/Volume Activity Price/Volume Activity Rating Relative Strength vs Market Bullish Chaikin Money Flow Price and volume activity for MRK is bullish. MRK has outperformed the S&P 500 over 26 weeks and has a rising price trend. Price Trend The rank for MRK is based on its price strength versus the market, negative Price Trend ROC Chaikin money flow, a positive Chaikin price trend, a negative Chaikin price trend ROC and an increasing volume trend. Volume Trend Relative Strength vs S&P500 Index Chaikin Money Flow Chart shows whether MRK is performing better or worse than the market. Chaikin Money Flow analyzes supply and demand for a companys stock. Price Activity Price Activity Volume Activity Factor Value Factor Value Factor Value 52 Week High 37.58 % Change Price - 4 Weeks 10.57% Average Volume 20 Days 16,385,914 52 Week Low 29.81 % Change Price - 24 Weeks 1.01% Average Volume 90 Days 15,104,853 % Change YTD Rel S&P 500 -3.78% % Change Price - 4 Wks Rel to S&P 3.38% Chaikin Money Flow Persistency 34% % Change Price - 24 Wks Rel to S&P 9.35% Expert Opinions Expert Opinions Earnings Estimate Revisions Very Bullish Short Interest Expert opinions about MRK are very positive. Shorting of MRK is low and analystss opinions on MRK have been more positive recently. Insider Activity The rank for MRK is based on a low short interest ratio, insiders purchasing stock, optimistic analyst opinions and price strength of the stock versus the Drugs Analyst Opinions industry group. Relative Strength vs Industry Earnings Estimate Revisions Analyst Recommendations EPS Estimates Revision Summary Current 7 Days Ago % Change Factor Value Last Week Last 4 Weeks Current Qtr 0.90 0.90 0.00% Mean this Week Buy Up Down Up Down Next Qtr 0.96 0.96 0.00% Mean Last Week Buy Curr Qtr 0 0 0 0 Curr Yr 0 0 0 2 Current 30 Days Ago % Change Change 0.00 Next Qtr 0 0 0 0 Current FY 3.73 3.73 0.00 Mean 5 Weeks Ago Buy Next Yr 0 0 0 2 I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
  4. 4. The Company & Its Competitors MRKs Competitors in Drugs News Headlines for MRK Company Power Historic EPS Projected EPS Profit Margin PEG PE Revenue(M) Orasure Technologies reports second-quarter Gauge growth growth loss - Aug 4, 2011 MRK 18.19% 3.25% 6.13% 2.72 9.16 45,987 FeminaPharma NuvaRing 08 02 - Aug 2, 2011 JNJ 4.21% 6.00% 18.32% 2.20 13.38 61,587 Mercks Wilson plant adding jobs - Aug 1, 2011 NVS 9.55% 4.71% 18.05% 2.16 10.62 50,624 Earnings Preview: Bristol-Myers reports 2Q results - Jul 26, 2011 PFE 6.66% 4.00% 12.78% 2.12 8.60 67,809 Femina NuvaRing 07 20 - Jul 20, 2011 SNY 4.26% 1.30% 16.81% 5.61 8.76 41,395 GSK 3.26% 4.82% 11.92% 2.36 11.70 45,905 Company Details Company Profile MERCK & CO INC Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to ONE MERCK DRIVE P.O. BOX putting patients first. Established in 1891, Merck discovers, develops, manufactures and 100 markets vaccines and medicines to address unmet medical needs. The company devotes WHITEHOUSE STATION, NJ extensive efforts to increase access to medicines through far-reaching programs that not 08889-0100 only donate Merck medicines but help deliver them to the people who need them. Merck USA also publishes unbiased health information as a not-for-profit service. Phone: 908-423-4840 Fax: 908-298-7082 Website: http:// Full Time Employees: 94,000 Sector: Medical Power Gauge Ratings are created using a relative ranking system that assigns a rank of 0 to 100 (100 being the highest) to each stock in the universe. Rank is calculated by evaluating each of the stocks factors and combining them into a single number using a weighting formula. A stocks rank ranges from 100-0, where 100 is the strongest, and a rank of 95 indicates the stock is better than 95% of the stocks in the universe. Chaikin Stock Research(CSR) is not registered as a securities broker dealer or investment advisor with either the U.S. Securities and Exchange Commission or with any state securities regulatory authority. CSR is not responsible for trades executed by users of this research report, our web site or mobile app based on the information included herein. The information presented in this report does not represent a recommendation to buy or sell stocks or any financial instrument nor is it intended as an endorsement of any security or investment. The information in this report is generic by nature and is not personalized to the specific financial situation of any individual. The user bears complete responsibility for their own investment research and should seek the advice of a qualified investment professional before making any investment decisions. Copyright (c) 1978-(Present) by ZACKS Investment Research, Inc ("ZACKS"). The information, data, analyses and opinions contained herein (1) includes the confidential and proprietary information of ZACKS, (2) may not be copied or redistributed, for any purpose, (3) does not constitute investment advice offered by ZACKS, (4) are provided solely for informational purposes, and (5) are not warranted or represented to be correct, complete, accurate or timely. ZACKS shall not be responsible for investment decisions, damages or other losses resulting from, or related to, use of this information, data, analyses or opinions. Past performance is no guarantee of future performance. ZACKS is not affiliated with Chaikin Power Tools. This report from Chaikin Power Tools is for informational purposes only and is not a recommendation to buy or sell securities. LM 2.3 DS 3.0 LS 2.1 Data Provided by ZACKS Investment Research, Inc., Special offers to trade stocks from optionsXpress: